Data as of 3:59pm ET
| +0.08 / +5.88%|
Athersys, Inc. operates as a biopharmaceutical company, which is engaged in the discovery and development of therapies designed to extend and enhance the quality of human life. It establishes product development programs through the application of proprietary technologies in the field of regenerative medicine. The company's product development program, MultiStem, a proprietary off the shelf stem cell product used to treat indications in the inflammatory & immune, neurological and cardiovascular disease areas. Athersys was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH.
|Gil van Bokkelen||Chairman & Chief Executive Officer|
|William B. J. Lehmann||President, Chief Operating Officer & Secretary|
|Laura K. Campbell||Vice President-Finance|
|John J. Harrington||Director, Chief Scientific Officer & Executive VP|
|Manal Morsy||Vice President & Head-Global Regulatory Affairs|